The Valley Desk

NCT04038502 · Interventional trial

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

Overall registry status Recruiting

Phase 2

Conditions BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2, Metastatic Castrate Resistant Prostate Cancer, RAD51B, RAD51C, RAD51D, or RAD54L Mutations

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov